Clinical trial
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With…
NCT00037115 · MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute, Other · Withdrawn
Key facts
| NCT number | NCT00037115 |
|---|---|
| Title | Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. |
| Official title | An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results. |
| Lead sponsor | MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute, Other |
| Collaborators | Consultants in Neurology Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Demyelinating Disorders, Multiple Sclerosis, Optic Neuritis, Myelitis, Neuritis |
| Intervention type | Drug |
| Interventions | interferon beta 1a, methotrexate, methylprednisolone |
| Enrollment | 0 |
| Start date | May 1, 2002 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | May 17, 2002 |
| Last update posted | Apr 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: